Search

Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca's data sharing policy described at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure. Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial Ninety-six patients (including 26 adolescents) and 98 patients (27 adolescents) were randomized into the benralizumab and placebo groups, respectively. [Extracted from the article]

The article discusses the study on the development of major depressions in older people with minor or subsyndromal depression. Information on the design of the study, the setting and the date the study was conducted, and the covered population were also provided. The author also states that the study reflects the history of depressive conditions during usual primary care.

The article focuses on patients with mild depression. Sadness or loss of interest can be caused by depression. It is defined as the medical condition that reflects the deviation in behavior from a normal reaction to life situations. To begin a study related to mental depression, each of the patients should be tested for symptoms of depression. It has been viewed that patients with minor or subsyndromal depression are at a higher risk for major depression than patients who have no depression symptoms.